Cargando…

Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine

Francisella tularensis (F. tularensis) is an intracellular pathogen that causes a potentially debilitating febrile illness known as tularemia. F. tularensis can be spread by aerosol transmission and cause fatal pneumonic tularemia. If untreated, mortality rates can be as high as 30%. To study the ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yie-Hwa, Duong, Duc M., Goll, Johannes B., Wood, David C., Jensen, Travis L., Yin, Luming, Gelber, Casey E., Seyfried, Nicholas T., Anderson, Evan, Natrajan, Muktha S., Rouphael, Nadine, Johnson, Robert A., Sanz, Patrick, Mulligan, Mark J., Hoft, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564149/
https://www.ncbi.nlm.nih.gov/pubmed/32722207
http://dx.doi.org/10.3390/vaccines8030413
_version_ 1783595646641504256
author Chang, Yie-Hwa
Duong, Duc M.
Goll, Johannes B.
Wood, David C.
Jensen, Travis L.
Yin, Luming
Gelber, Casey E.
Seyfried, Nicholas T.
Anderson, Evan
Natrajan, Muktha S.
Rouphael, Nadine
Johnson, Robert A.
Sanz, Patrick
Mulligan, Mark J.
Hoft, Daniel F.
author_facet Chang, Yie-Hwa
Duong, Duc M.
Goll, Johannes B.
Wood, David C.
Jensen, Travis L.
Yin, Luming
Gelber, Casey E.
Seyfried, Nicholas T.
Anderson, Evan
Natrajan, Muktha S.
Rouphael, Nadine
Johnson, Robert A.
Sanz, Patrick
Mulligan, Mark J.
Hoft, Daniel F.
author_sort Chang, Yie-Hwa
collection PubMed
description Francisella tularensis (F. tularensis) is an intracellular pathogen that causes a potentially debilitating febrile illness known as tularemia. F. tularensis can be spread by aerosol transmission and cause fatal pneumonic tularemia. If untreated, mortality rates can be as high as 30%. To study the host responses to a live-attenuated tularemia vaccine, peripheral blood mononuclear cell (PBMC) samples were assayed from 10 subjects collected pre- and post-vaccination, using both the 2D-DIGE/MALDI-MS/MS and LC-MS/MS approaches. Protein expression related to antigen processing and presentation, inflammation (PPARγ nuclear receptor), phagocytosis, and gram-negative bacterial infection was enriched at Day 7 and/or Day 14. Protein candidates that could be used to predict human immune responses were identified by evaluating the correlation between proteome changes and humoral and cellular immune responses. Consistent with the proteomics data, parallel transcriptomics data showed that MHC class I and class II-related signals important for protein processing and antigen presentation were up-regulated, further confirming the proteomic results. These findings provide new biological insights that can be built upon in future clinical studies, using live attenuated strains as immunogens, including their potential use as surrogates of protection.
format Online
Article
Text
id pubmed-7564149
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75641492020-10-26 Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine Chang, Yie-Hwa Duong, Duc M. Goll, Johannes B. Wood, David C. Jensen, Travis L. Yin, Luming Gelber, Casey E. Seyfried, Nicholas T. Anderson, Evan Natrajan, Muktha S. Rouphael, Nadine Johnson, Robert A. Sanz, Patrick Mulligan, Mark J. Hoft, Daniel F. Vaccines (Basel) Article Francisella tularensis (F. tularensis) is an intracellular pathogen that causes a potentially debilitating febrile illness known as tularemia. F. tularensis can be spread by aerosol transmission and cause fatal pneumonic tularemia. If untreated, mortality rates can be as high as 30%. To study the host responses to a live-attenuated tularemia vaccine, peripheral blood mononuclear cell (PBMC) samples were assayed from 10 subjects collected pre- and post-vaccination, using both the 2D-DIGE/MALDI-MS/MS and LC-MS/MS approaches. Protein expression related to antigen processing and presentation, inflammation (PPARγ nuclear receptor), phagocytosis, and gram-negative bacterial infection was enriched at Day 7 and/or Day 14. Protein candidates that could be used to predict human immune responses were identified by evaluating the correlation between proteome changes and humoral and cellular immune responses. Consistent with the proteomics data, parallel transcriptomics data showed that MHC class I and class II-related signals important for protein processing and antigen presentation were up-regulated, further confirming the proteomic results. These findings provide new biological insights that can be built upon in future clinical studies, using live attenuated strains as immunogens, including their potential use as surrogates of protection. MDPI 2020-07-24 /pmc/articles/PMC7564149/ /pubmed/32722207 http://dx.doi.org/10.3390/vaccines8030413 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chang, Yie-Hwa
Duong, Duc M.
Goll, Johannes B.
Wood, David C.
Jensen, Travis L.
Yin, Luming
Gelber, Casey E.
Seyfried, Nicholas T.
Anderson, Evan
Natrajan, Muktha S.
Rouphael, Nadine
Johnson, Robert A.
Sanz, Patrick
Mulligan, Mark J.
Hoft, Daniel F.
Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
title Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
title_full Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
title_fullStr Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
title_full_unstemmed Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
title_short Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
title_sort proteomic analysis of human immune responses to live-attenuated tularemia vaccine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564149/
https://www.ncbi.nlm.nih.gov/pubmed/32722207
http://dx.doi.org/10.3390/vaccines8030413
work_keys_str_mv AT changyiehwa proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT duongducm proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT golljohannesb proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT wooddavidc proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT jensentravisl proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT yinluming proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT gelbercaseye proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT seyfriednicholast proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT andersonevan proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT natrajanmukthas proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT rouphaelnadine proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT johnsonroberta proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT sanzpatrick proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT mulliganmarkj proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine
AT hoftdanielf proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine